1. Scientific publications
2. Books and book chapters
3. Scientific reports, biosafety recommendations, technical notes

 

 

1. Scientific publications

Onnockx S, Baldo A, Pauwels K. Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment. Vaccines 2023, 11, 1448

Sturme MHJ, van der Berg JP, Bouwman LMS, De Schrijver A, de Maagd RA, Kleter GA, Battaglia-de Wilde E (2022). Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants. ACS Agric. Sci. Technol. 2 (2), 192-201

Baldo A, Leunda A, Willemarck N, Pauwels K (2021) Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2. Vaccines, 9 (5):453

Coppens F, Willemarck N, Breyer D (2019) Opinion: Airtightness for Decontamination by Fumigation of High-Containment Laboratories. Applied Biosafety, 24 (4): 207-212

Baldo A, Welby S, Do Thi CD, Leunda A, Herman P, Breyer D (2018) Risk Classification of Zoonotic Microorganisms: Development of a One Health Approach Tool Applied to HPAI A H5N1 Viruses. Applied Biosafety, 23 (4): 199-210

Bogdanove AJ, Donovan DM, Elorriaga E, Kuzma J, Pauwels K, Strauss SH, Voytas DF (2018) Genome Editing in Agriculture: Methods, Applications, and Governance. A paper in the series on The Need for Agricultural Innovation to Sustainably Feed the World by 2050. Council for Agricultural Science and Technology (CAST), Issue Paper 60. CAST, Ames, Iowa

Van der Vlugt CJB, Brown DD, Lehmann K, Leunda A, Willemarck N (2018) A Framework for the Risk Assessment and Management of Gene Drive Technology in Contained Use. Applied Biosafety 23 (1): 25-31

Fraiture MA, Roosens NH, Taverniers I, De Loose M, Deforce D, Herman P (2016) Biotech rice: Current developments and future detection challenges in food and feed chain. Trends in Food Science & Technology 52 (2): 66-79

De Schrijver A, Devos Y, De Clercq P, Gathmann A, Romeis J (2016) Quality of laboratory studies assessing effects of Bt-proteins on non-target organisms: minimal criteria for acceptability. Transgenic Research 25 (4): 395–411

Baldo A, Galanis E, Tangy F, Herman P (2016) Biosafety Considerations for Attenuated Measles Virus Vectors Used in Virotherapy and Vaccination. Human Vaccines & Immunotherapeutics 12 (5): 1102-1116

Willems S, Fraiture MA, Deforce D, De Keersmaecker SCJ, De Loose M, Ruttink T, Herman P, Van Nieuwerburgh F, Roosens N (2016) Statistical framework for detection of genetically modified organisms based on Next Generation Sequencing. Food Chemistry 192: 788-798

Fraiture MA, Herman P, Taverniers I, De Loose M, Deforce D, Roosens NH (2015) Current and New Approaches in GMO Detection: Challenges and Solutions. BioMed Research International. Article ID 392872, 22 pages

Fraiture MA, Herman P, Lefèvre L, Taverniers I, De Loose M, Deforce D, Roosens NH (2015) Integrated DNA walking system to characterize a broad spectrum of GMOs in food/feed matrices. BMC Biotechnol 15 (76): 1-11

Pauwels K, De Keersmaecker SCJ, De Schrijver A, Du Jardin P, Roosens NHC, Herman P (2015) Next-Generation sequencing as a tool for the molecular characterisation and risk assessment of genetically modified plants: added value or not? Trends in Food Science & Technology 45 (2): 319-326

De Schrijver A, De Clercq P, de Maagd R, van Frankenhuyzen K (2015) Relevance of Bt toxin interaction studies for environmental risk assessment of genetically modified crops. Plant Biotechnology Journal 13 (9): 1221-1223

Fraiture MA, Herman P, Taverniers I, De Loose M, Van Nieuwerburgh F, Deforce D, Roosens NH (2015) Validation of a sensitive DNA walking strategy to characterise unauthorised GMOs using model food matrices mimicking common rice products. Food Chemistry 173: 1259-1265.

Leunda A, Baldo A, Goossens M, Huygen K, Herman P, Romano M (2014) Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations. Vaccines 2 (2):463-499

Breyer D, Kopertekh L, Reheul D (2014) Alternatives to Antibiotic Resistance Marker Genes for In Vitro Selection of Genetically Modified Plants - Scientific Developments, Current Use, Operational Access and Biosafety Considerations. Critical Reviews in Plant Sciences 33 (4):286-330

Kok E, Pedersen J, Onori R, Sowa S, Schauzu M, De Schrijver A, Teeri TH (2014) Plants with stacked genetically modified events: to asses or not to assess? Trends in Biotechnology 32 (2):70-73

Pauwels K, Podevin N, Breyer D, Carroll D, Herman P (2014) Engineering nucleases for gene targeting: safety and regulatory considerations. New Biotechnology 31 (1):18-27

Carstens K, Cayabyab B, De Schrijver A, Gadaleta PG, Hellmich RL, Romeis J, Storer N,Valicente FH, Wach M (2014) Surrogate species selection for assessing potential adverse environmental impacts of genetically engineered insect-resistant plants on non-target organisms. GM Crops and Food: Biotechnology in Agriculture and the Food Chain 5 (1): 1-5

Fraiture MA, Herman P, Taverniers I, De Loose M, Deforce D, Roosens NH (2014) An innovative and integrated approach based on DNA walking to identify unauthorised GMOs. Food Chemistry 147: 60-69

Lim F, Khalique H, Ventosa M, Baldo A (2013) Biosafety of vectors derived from Herpes Simplex Virus Type 1. Current Gene Therapy 13 (6): 478-491

Goossens M, Pauwels K, Willemarck N, Breyer D (2013) Environmental risk assessement of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Current Gene Therapy 13 (6): 413-420

Baldo A, van den Akker E, Bergmans H, Lim F, Pauwels K (2013) General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination. Current Gene Therapy 13 (6): 385-394

Herman P (2013) Guest Editor Preface. Current Gene Therapy 13 (6): 383-384

Leunda A, Van Vaerenbergh B, Baldo A, Roels S, Herman P (2013) Laboratory activities involving transmissible spongiform encephalopathy causing agents: Risk assessment and biosafety recommendations in Belgium. Prion 7 (5): 420-433

Do Thi CD, Leunda A, Van Vaerenbergh B, Herman P (2013) High-containment Level Facilities Handling Pathogenic Organisms in Belgium: An Overview. Applied Biosafety 18 (3):122-131

Pauwels K, Mampuys R, Golstein C, Breyer D, Herman P, Kaspari M, Pagès JC, Pfister H, van der Wilk F, Schönig B (2013) Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology. Journal für Verbraucherschutz und Lebensmittelsicherheit - Journal of Consumer Protection and Food Safety 8 (3): 215-226

Baldo A, Leunda A, Do Thi CD, Breyer D, Pauwels K, Welby S, Van Vaerenbergh B, Herman P (2013) Biosafety Risk Assessment and Management of Laboratory-derived Influenza A (H5N1) Viruses Transmissible in Ferrets. Applied Biosafety 18 (1):6-17

Dickx V, Van Droogenbroeck C, Van Vaerenbergh B, Herman P, Braeckman L, Vanrompay D (2012) Chlamydia psittaci, Causative Agent of Avian Chlamydiosis and Human Psittacosis: Risk Assessment and Biosafety Recommendations. Applied Biosafety 17 (2):85-88

Devos Y*, De Schrijver A*, De Clercq P, Kiss J, Romeis J (2012) Bt-maize event MON 88017 expressing Cry3Bb1 does not cause harm to non-target organisms. Transgenic Research, 21 (6):1191-1214.
* contributed equally to the work, should be considered co-first authors.

Pauwels K (2012) Are ‘OMICS’ Contributing to the Identification of Unintended Effects in Genetically Modified Crops? Biosafety 1 (1)

Verheust C, Goossens M, Pauwels K, Breyer D (2012) Biosafety aspects of Modified Vaccinia Virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine 30 (16):2623-2632

Pauwels K, Breyer D, De Schrijver A, Goossens M, Herman P (2010) Contributions from Scientific Research to the Risk Assessment of GMOs. Lessons learned from a Symposium Held in Brussels, Belgium, 21-22 October 2010. Environmental Biosafety Research 9 (3):113-121

Carstens K, Anderson J, Bachman P, De Schrijver A, et al. (2011) Genetically modified crops and aquatic ecosystems: considerations for environmental risk assessment and non-target organism testing. Transgenic Research 21 (4):813-842

Sanvido O, De Schrijver A, Devos Y, Bartsch D (2011) Post Market Environmental Monitoring of Genetically Modified Herbicide Tolerant Crops (Working group report from the 4th International workshop on PMEM of Genetically Modified Plants, Quedlinburg, Germany 2010). Journal für Kulturpflanzen 63 (7), 211-216

Romeis J, Hellmich RL, Candolfi MP, Carstens K, De Schrijver A, Gatehouse AM, Herman RA, Huesing JE, MA McLean, Raybould A, Shelton AM, Waggoner A (2011) Recommendations for the design of laboratory studies on non-target arthropods for risk assessment of genetically engineered plants. Transgenic Research 20 (1):1-22

Van Vaerenbergh B, Koenen F, Pauwels K, Quanten K, Boyen F, Declercq K, Desmecht D, Thiry J, Herman P (2010). Methodology of the biological risk classification of animal pathogens in Belgium. Rev Sci Tech 29 (3):513-22

Verheust C, Pauwels K, Helinski D, Mahillon J, Herman P (2010) Contained Used of Bacteriophages: Risk Assessment and Biosafety Recommendations. Applied Biosafety 15 (1):32-44

Breyer D, Herman P, Brandenburger A, Gheysen G, Remaut E, Soumillion P, J Van Doorsselaere, Custers R, Pauwels K, Sneyers M, Reheul D (2009) Should Novel Organisms Developed Using Oligonucleotide-mediated Mutagenesis Be Excluded from the EU Regulation? ISB NEWS REPORT.

Breyer D, Goossens M, Herman P, Sneyers M (2009) Biosafety considerations associated with molecular farming in genetically modified plants. Journal of Medicinal Plants Research 3 (11):825-838

Breyer D, Roosens N, Berben G, Taverniers I, Van den Bulcke M, Sneyers M (2009) European project Co-Extra: GM and non-GM supply chains: their co-existence and traceability. Labinfo, N°3

Collard JM, Breyer D, Renckens S, Sneyers M, Van Haver E, Van Vaerenbergh B, Moens W (2009) Biosafety in Biotechnology. Encyclopedia of Life Support Systems (EOLSS). UNESCO-EOLSS Publishers Co Ltd.

Pauwels K, Gijsbers R, Toelen J, Schambach A, Willard-Gallo K, Verheust C, Debyser Z, Herman P (2009) State-of-the-art lentiviral vectors for research use: Risk assessment and biosafety recommendations. Current Gene Therapy 9 (6):459-474

Devos Y, De Schrijver A, Reheul D (2009) Quantifying the introgressive hybridisation propensity between transgenic oilseed rape and its wild/weedy relatives. Environ Monit Assess 149 (1-4):303-322

Breyer D, Herman P, Brandenburger A, Gheysen G, Remaut E, Soumillion P, Van Doorsselaere J, Custers R, Pauwels K, Sneyers M, Reheul D (2009) Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge? Environ. Biosafety Res 8 (2):57-64

Graef F, De Schrijver A, Murray B (2008). GMO monitoring data coordination and harmonisation at EU level - Outcomes of the European Commission Working Group on Guidance Notes supplementing Annex VII of Directive 2001/18/EC. Journal für Verbraucherschutz und Lebensmittelsicherheit 3 (Sup 2):17-20

Devos Y, De Schrijver A, Reheul D (2007). Using an oilseed rape x wild /weedy relative gene flow index for the monitoring of transgenic oilseed rape. Journal für Verbraucherschutz und Lebensmittelsicherheit 2 (Sup1):88-89

Pauwels K, Herman P, Van Vaerenbergh B, Do Thi CD, Berghmans L, Waeterloos G,  Van Bockstaele D, Dorsch-Häsler K, Sneyers M (2007) Animal Cell Cultures: Risk Assessment and Biosafety Recommendations. Applied Biosafety 12 (1):27-39

Breyer D, Daubresse P, Sneyers M (2007) Bringing scientists to the people - the Co-Extra website. Biotechnology Journal. 2 (9):1081 -1085

De Schrijver A, Devos Y, Van den Bulcke M, Cadot P, De Loose M, Reheul D, Sneyers M (2007) Risk assessment of GM stacked events obtained from crosses between GM events. Trends in Food Science and Technology 18:101-109

Devos Y, Reheul D, De Schrijver A (2006) Considerations of cross-fertilization between GM and non-GM maize. ISB News Report, March 2006

Sneyers M, Herman P, Moens W (2005) Polio eradication and laboratory containment program of wild polioviruses in Belgium: Laboratory survey and inventory phase. Arch of Pub Health 63:57

Devos Y, Reheul D, De Schrijver A (2005) The co-existence between transgenic and non-transgenic maize in the European Union: a focus on pollen flow and cross-fertilization. Environmental Biosafety Res 4:71-87

Herman P, Verlinden Y, Breyer D, Van Cleemput E, Brochier B, Sneyers M, Snacken R, Hermans P, Kerkhofs P, Liesnard C, Rombaut B, Van Ranst M, Van Der Groen G, Goubau P, Moens W (2004). Biosafety risk assessment of the severe acute respiratory syndrome (SARS) Coronavirus and containment measures for the diagnostic and research laboratories. Applied Biosafety. 9 (3):128-142

Devos Y, Reheul D, De Schrijver A, Cors F, Moens W (2004) Management of herbicide-tolerant oilseed rape in Europe: a case study on minimizing vertical gene flow. Environmental Biosafety Res 3:135-148

Devos Y, De Schrijver A(2003) Genetisch gewijzigd voedsel: Reglementering en veiligheidsbeoordeling. Nutrinews 3:12-17

Moens W (2003) Guest Editor. Biosafety of Virus-Derived Vectors. Current Gene Therapy, 3 (6)

Sneyers M, Dumon JC, Van Vaerenbergh B, Moens W (2001) Gene Therapy Clinical Trials in Belgium. Human Gene Therapy, 12:1361-1365

Breyer D, Moens W (2000) Le protocole sur la biosécurité: test de crédibilité pour l’avenir de la Convention sur la diversité biologique ? Bulletin de l'Institut Royal des Sciences naturelles de Belgique, 70-Suppl:45-52

Doblhoff-Dier O, Bachmayer H, Bennett A, Brunius G, Cantley M, Collins C, Collard JM, Crooy P, Elmqvist A, Frontali-Botti C, Gassen HG, Havenaar R, Haymerle H, Lamy D, Lex M, Mahler JL, Martinez L, Mosgaard C, Olsen L, Pazlarova J, Rudan F, Sarvas M, Stepankova H, Tzotzos G, Wagner K, Werner R (2000). Safe Biotechnology. 10. DNA content of biotechnological process waste. Trends in Biotechnol (TIBECH). 18:141-46

Sneyers M (1999) Regulation of Gene Therapy in Belgium. Euregenethy, a scientific network of users. Regulation of Gene Therapy in Europe, 1:3-5

Collard JM, Breyer D, Sneyers M, Van Vaerenbergh B, Moens W (1998). Manipulation d'organismes pathogènes ou génétiquement modifiés dans les hôpitaux. Aspects biosécuritaires et réglementaires. L'Hôpital Belge/Het Belgisch Ziekenhuis 4:55-62

Lelieveld HLM, Bachmayer H, Boon B, Bennett A, Brunius G, Bürki K, Cantley M, Collard JM, Collins CH, Crooy P, Doblhoff-Dier O, Dubakiene R, Economidis I, Elmqvist A, Frontali-Botti C, Havenaar R, Haymerle H, Käppeli O, Leaver G, Lex M, Lund S, Mahler JL, Marris R, L. J. Martinez, Mosgaard C, Nicu M, Normand-Plessier C, Olsen J, Pazlerova J, Romantschuk M, Rudan F, Sarvas M, Schlumberger HD, Szvoboda G, Stepankova H, Tzotzos G, Vaicuivenas V, Wagner K, R. G. Werner, Zhilevicha A (1997) Safe Biotechnology. 8. Transport of infectious and biological materials. Appl. Microbiol. Biotechnol 48:135-140

2. Books and book chapters

Leunda A, Pauwels K (2019) GMO Regulatory Aspects of Novel Investigational Vaccine Candidates. in Vaccines

Glandorf D, Breyer D (2016) Field Trials with GM Trees: A Step-by-Step Approach. Volume 82 of the series Forestry Sciences pp 141-154, In C.Vettori, F. Gallardo, H. Häggman, V. Kazana, F. Migliacci, G. Pilate, M. Fladung (Eds), Biosafety of Forest Transgenic Trees. Improving the Scientific Basis for Safe Tree Development and Implementation of EU Policy Directives, Springer, ISBN 978-94-017-7529-8, ISBN 978-94-017-7531-1 (eBook)

Herman P, Pauwels K (2015). Biosafety Recommendations on the Handling of Animal Cell Cultures. Chapter 22, Vol 9, Cell engineering: Animal Cell Culture. M. Al Rubeai (Ed.), Springer series. ISBN 978-3-319-10319-8, ISBN 978-3-319-10320-4 (eBook)

Breyer D, De Schrijver A, Goossens M, Pauwels K, Herman P (2011) Biosafety of molecular farming in genetically modified plants. In Wang, Aiming; Ma, Shengwu (Eds.), Molecular Farming in Plants: Recent Advances and Future Prospects, Springer, ISBN 978-94-007-2216-3

Breyer D, Brosius B, De Schrijver A, Do Thi CD, Goossens M, Leunda A, Pauwels K, Sneyers M, Van Droegenbroeck C, Van Vaerenbergh B, Verheust C, Herman P (2010) The Scientific Institute of Public Health, Belgian focal point for Biosafety. 1990-2010: 20 years of risk assessment of GMOs and pathogens. ISBN 9789074968287. Ref : D/2010/2505/43

Breyer D, Brosius B, De Schrijver A, Do Thi CD, Goossens M, Leunda A, Pauwels K, Sneyers M, Van Droegenbroeck C, Van Vaerenbergh B, Verheust C, Herman P (2010) L’Institut scientifique de Santé publique, point focal belge pour la Biosécurité. 1990-2010: 20 années d’évaluation des risques des OGM et pathogènes. ISBN 9789074968287. Ref : D/2010/2505/41

Breyer D, Brosius B, De Schrijver A, Do Thi CD, Goossens M, Leunda A, Pauwels K, Sneyers M, Van Droegenbroeck C, Van Vaerenbergh B, Verheust C, Herman P (2010) Het Wetenschappelijk Instituut Volksgezondheid, Belgisch brandpunt voor Bioveiligheid. 1990-2010: 20 jaar risicobeoordeling van GGO’s en pathogenen. ISBN 9789074968287Ref : D/2010/2505/42

3. Scientific reports, biosafety recommendations, technical notes

Breyer D, Baldo A, Johansen TB, Coppens F, Forsman M, Fyske EM, Madslien EH, Jones J, Limonier F, Rutjes S (2024). Synthetic Biology - Risk assessments and recommendations for future governance guidelines. EU Joint Action TERROR, WP 8.2.

Baldo A, Descamps E, Do Thi CD, Leunda A, Willemarck N, Breyer D (2021) Gestion des déchets biologiquement contaminés produits lors des activités d’utilisation confinée d’organismes génétiquement modifiés et/ou pathogènes; Lignes directrices et recommandations. Ref: D/2021/14.440/94

Baldo A, Descamps E, Do Thi CD, Leunda A, Willemarck N, Breyer D (2021) Beheer van biologisch besmet afval afkomstig van activiteiten van ingeperkt gebruik van genetisch gemodificeerde en/of pathogene organismen: Richtlijnen en aanbevelingen. Ref: D/2021/14.440/95

Willemarck N, Smets G, Descamps E, Coppens F, Rudelsheim P (2018) Monitoring of Laboratory-Acquired Infections. COGEM Onderzoeksrapport CGM 2018-01.

Descamps E, Willemarck N, Moens T (2017) Bioveiligheid in onderwijsactiviteiten met biologische agentia: jong geleerd is oud gedaan. Ref: D/2017/3241/111. Aanvullende informatie.

Descamps E, Willemarck N, Moens T (2017) La biosécurité des activités d'enseignement où sont manipulés des agents biologiques: ce qui est appris jeune est acquis pour toujours. Réf: D/2017/2505/05. Données complémentaires.

Coppens F, Willemarck N (2016) Airtightness in Belgian high biocontainment facilities. Ref: D/2016/2505/14

Fraiture MA, Herman P, Papazova N, Roosens N (2015) UGM characterization using DNA walking strategy. AFSCA/FAVV Labinfo nr 14, December 2015, pp. 32-34.

Willemarck N, Van Vaerenbergh B, Descamps E, Brosius B, Do Thi CD, Leunda A, Baldo A (2015) Laboratory-Acquired Infections in Belgium (2007-2012): An online survey.  Ref: D/2015/2505/08.

De Schrijver A, De Clercq P, Booij K, de Maagd RA, van Frankenhuyzen K (2014). Can interactions between Bt proteins be predicted and how should effects on non-target organisms of GM crops with multiple Bt Proteins be assessed? COGEM Report CGM 2014-05.

Willemarck N, Brosius B, Van Vaerenbergh B, Leunda A, Baldo A, Do Thi CD (2013) Laboratory-Acquired Infections in Flanders (2007-2012): An online survey. Ref: D/2012/2505/59.

Fraiture MA, Herman P, Berben G, Debode F, Janssen E, Taverniers I, De Loose M, Roosens N (2013) New techniques and methods developed by the Belgian NRL-GMO to identify unauthorized GMOs in the UGMMONITOR project. AFSCA/FAVV Labinfo nr 9, January 2013, pp. 25-27.

Goossens M, Herman P (2012) La Biotechnologie "rouge" en Belgique: cadre juridique et biosécurité des OGM médicinaux. MEDI-SPHERE 395, 14 juin 2012.

Goossens M, Herman P (2012) "Rode Biotechnologie" in België: juridisch kader en bioveilighied van medicinale GGO's. MEDI-SFEER 395, 14 juni 2012.

Van Vaerenbergh B, Willemarck N, Brosius B, Leunda A, Baldo A, Do Thi CD (2012). Effluent Decontamination systems: Design, operation and safety. Ref: D/2012/2505/58.

Pauwels K, Willemarck N, Breyer D, Herman P (2012). Synthetic Biology. Latest developments, biosafety considerations and regulatory challenges. Ref: D/2012/2505/46.

Pauwels K, Breyer D, De Schrijver A, Goossens M, Herman P (2012). Involving the scientific community in the risk assessment of GMOs. A continuous task for the Biosafety and Biotechnology Unit. Scientific Report 2010 | 2011 WIV-ISP. Ref: D/2012/2505/19, pp. 88 – 89.

Van Vaerenbergh B, Van Droogenbroeck C, Do Thi CD, Verheust C, Willemarck N, Brosius B, Leunda A (2012). Biosafety in laboratory animal facilities. Scientific Report 2010 | 2011 WIV-ISP. Ref: D/2012/2505/19, pp. 90 – 92.

Van Vaerenbergh B, Do Thi CD, Verheust C, Willemarck N (2011). Biosafety in laboratory animal facilities. A practical approach. Ref: D/2011/2505/47.

Leunda A, Do Thi CD, Verheust C, Van Vaerenbergh B, Pauwels K, Herman P (2011). Modaliteiten voor validatie en controle van autoclaven in het kader van inactivatie van afval afkomstig van ingeperkt gebruik van genetisch gemodificeerde organismen en/of pathogenen. Ref: D/2011/2505/46.

Leunda A, Do Thi CD, Verheust C, Van Vaerenbergh B, Pauwels K, Herman P (2011). Modalités de validation et de contrôle des autoclaves dans le cadre de l’inactivation des déchets résultants d’utilisations confinées d’organismes génétiquement modifiés et/ou pathogènes. Ref : D/2011/2505/39.

Do Thi CD, Leunda A, Verheust C (2011). Le manuel de biosécurité, Canevas et guide de rédaction. Ref : D/2011/2505/25.

Leunda A, Pauwels K, Van Vaerenbergh B, Herman P (2010). Sampling feasibility study of pathogenic organisms genetically modified or not in contained use activities. Ref: D/2010/2505/19.

Van Vaerenbergh B, Koenen F, Pauwels K, Quanten K, Boyen F, Declercq K, Desmecht D, Thiry J, Herman P (2010). Methodology of the biological risk classification of animal pathogens in Belgium. Scientific Report 2008 | 2009 WIV-ISP. Ref: D/2010/2505/52, pp. 135 -140.

Breyer D, Pauwels K, Herman P (2010). New techniques of genetic modification and the GMO definition. Scientific Report 2008 | 2009 WIV-ISP. Ref: D/2010/2505/52, pp. 144 -146.

Pauwels K, Verheust C, Van Vaerenbergh B, Herman P (2009). Biological Risk Assessment Sheets: Practical Examples of Risk Assessment and Biosafety Recommendations for the Contained Use of Genetically Modified (Micro-)Organisms. Ref: D/2009/2505/48.

Leunda Casi A, Pauwels K, Herman P, Verheust C, Zorzi W, Thellin O, Van Vaerenbergh B (2009). Risk assessment of laboratories involving the manipulation of unconventional agents causing TSE. Ref: D/2009/2505/49.

Do Thi CD, Van Vaerenbergh B, Herman P, Pauwels K, Coppens F, Leunda Casi A, Verheust C (2009). Les installations de haut niveau de confinement en Belgique. Rapport: Période 1995 – 2008. Ref: D/2009/2505/40.

Do Thi CD, Van Vaerenbergh B, Herman P, Pauwels K, Coppens F, Leunda Casi A, Verheust C (2009). Inrichtingen met een hoog inperkingsniveau in België. Rapport: Periode 1995-2008. Ref: D/2009/2505/40.

Herman P, Breyer D, Coppens F, De Schrijver A, Do Thi CD, Leunda A, Goossens M, Pauwels K, Van Vaerenbergh B, Verheust C, Sneyers M (2009). L’évaluation des risques des organismes génétiquement modifiées et/ou pathogènes. Rapport d’activités 2007 | 2008 de l’ISP. N° D/2009/2505/55, pp 84-87.

Pauwels K, Herman P, Van Vaerenbergh B, C D. Do Thi, Berghmans L, Waeterloos G, D Van Bockstaele, Dorsch K, Sneyers M (2008). Animal cell cultures : Risk assessment and biosafety recommendations. Scientific Report, IPH, 2006 | 2007. N° D/2008/2505/25, pp 26-29.

Pauwels K, Coppens F, Verheust C, Van Vaerenbergh B, Do Thi CD, Herman P (2008). Emploi d’appareils de protection respiratoire durant l’utilisation confinée d’organismes génétiquement modifiés et/ou pathogènes. Ref: D/2008/2505/01.

Pauwels K, Coppens F, Verheust C, Van Vaerenbergh B, Do Thi CD, Herman P (2008). Gebruik van ademhalings-beschermingsmiddelen bij het ingeperkt gebruik van genetisch gemodificeerde organismen en/of pathogenen. Ref: D/2007/2505/64.

Berghmans L, Pauwels K, Van Vaerenbergh B, Do Thi CD, Herman P (2006). Bioveiligheidsaanbevelingen aangaande behandelings- en inactiveringsmethoden voor biologisch besmet afval. Ref: D/2006/2505/28. (Update: D/2021/14.440/95, zie hoger)

Berghmans L, Pauwels K, Van Vaerenbergh B, Do Thi CD, Herman P (2006). Recommandations de biosécurité relatives au traitement et aux méthodes d'inactivation des déchets biologiques contaminés. Ref: D/2006/2505/33. (Mise à jour: D/2021/14.440/94, voir plus haut)

Herman P, Fauville-Dufaux M, Breyer D, Van Vaerenbergh B, Pauwels K, Do Thi CD, Sneyers M, Wanlin M, Snacken R, Moens W (2006). Biosafety Recommendations for the Contained Use of Mycobacterium tuberculosis Complex Isolates in Industrialized Countries. Ref: D/2006/2505/22.

Pauwels K, Van Vaerenbergh B, Do Thi CD, Berghmans L, Herman P (2006). Negatieve luchtdruk bij L3 laboratoria. Ref: D/2006/2505/15.

Pauwels K, Van Vaerenbergh B, Do Thi CD, Berghmans L, Herman P (2006). Pression de l'air négative dans les laboratoires L3. Ref: D/2006/2505/15.

Herman P, Pauwels K (2006). Enceintes de Sécurité Microbiologique. Ref: D/2006/2505/20.

Herman P, Pauwels K (2006). Microbiologische veiligheidswerkkasten. Ref: D/2006/2505/20.

Sneyers M (2004). Report "Demonstrating the quality of implementing Polio laboratory containment requirements". Ref: D/2004/2505/03.

Van Haver E, De Schrijver A, Devos Y, Lievens S, Renckens S, Moens W (2003). Guidance notes for the safety assessment of genetically modified crops for food and feed use. Ref: D/2003/2505/16.

Devos Y, Renckens S, Moens W (2003). Guidance note for the compilation of the public dossier within the framework of the deliberate release of transgenic plants for experimental purposes. Ref: D/2003/2505/20.

Devos Y, Moens W (2003). Discussions of the working group on the protocol for growing GM Brassica in field releases. Ref: D/2003/2505/33.

Devos Y, Renckens S (2002). Antibiotica-resistentiegenen in transgene planten. Ref: D/2002/2505/28.

Van Haver E, Renckens S (2002). Food allergy of infants and the possible implications of genetically modified soybeans. Ref: D/2002/2505/32.

Dumon JC, Sneyers M, Moens W (2000). Report: First gene therapy related death. Ref: D/2000/2505/02.